©2024 Stanford Medicine
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life
Recruiting
Trial ID: NCT03021239
Purpose
The main purpose of this study is to compare Echo-guided testing to the Hemodynamic-Echo Ramp
Tests to determine which method of testing provides better information for adjusting pump
speed and medical treatment for Left Ventricular Assist Device (LVAD) patients. Better
adjustments may provide better quality of life, exercise tolerance and reduced unwanted
cardiac events over a 6-month period.
Official Title
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: A Multicenter Study
Eligibility
Inclusion Criteria:
1. Patient older than 18 years
2. Newly implanted HVAD
3. HVAD support anticipated for at least 6 months
4. Patient is ambulatory and discharged from hospital without inotropes
5. Patient is between 1 and 3 months post implant
6. Patient has not had a right heart catheterization since discharged from HVAD
implantation hospitalization
Exclusion Criteria:
1. The current HVAD is a replacement device
2. Patients currently has Right Ventricle (RV) failure requiring home inotropes
3. Inability to preformed right heart cath
4. Inadequate echocardiographic windows
Intervention(s):
procedure: Echo Guided Testing
procedure: Hemodynamic-Echo Ramp Testing -
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Dip Banerjee, MD